ATAI

Atai Beckley Inc.$7.33+0.00 (—)

Prev Close$7.29·MCap$2.70B·P/E—·Vol—·Yield0.93%

▲

Buys (12M)

0

$0.00

▼

Sells (12M)

0

$0.00

◆

Net Activity

Net Buyer

$0.00

●

Active Insiders

0

last 12 mo

ATAI Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 21, 2025	Craig Kevin James	Chief Medical Officer	Sell	11,563	$1.35	$15.6K	0
Mar 21, 2025	Johnson Anne Nagengast	Chief Financial Officer	Sell	33,545	$1.35	$45.3K	0
Mar 21, 2025	Kirpekar Sahil	Chief Business Officer	Sell	48,563	$1.35	$65.6K	0
Mar 21, 2025	Rao Srinivas	See Remarks	Sell	75,418	$1.35	$101.8K	0
Mar 21, 2025	Short Glenn Frank	Chief Scientific Officer	Sell	13,161	$1.35	$17.8K	0
Sep 26, 2024	ATAI Life Sciences N.V.	10% Owner	Sell	2,660,000	$6.05	$16.09M1.4% OS	0
May 16, 2024	Brand Florian	See Remarks	Sell	151,303	$1.92	$290.5K	0
Apr 2, 2024	Johnson Anne Nagengast	Chief Financial Officer	Sell	27,410	$1.85	$50.7K	0
Apr 2, 2024	Kirpekar Sahil	Chief Business Officer	Sell	35,801	$1.85	$66.2K	0
Apr 2, 2024	Rao Srinivas	See Remarks	Sell	61,640	$1.85	$114.0K	0
Nov 16, 2023	Brand Florian	See Remarks	Buy	20,000	$1.16	$23.1K	0
Sep 13, 2023	Brand Florian	See Remarks	Buy	40,000	$1.45	$58.0K	0
Mar 29, 2023	Brand Florian	See Remarks	Buy	70,000	$1.48	$103.6K	0
Jun 22, 2021	Angermayer Christian	Director	Buy	700,000	$15.00	$10.50M	0
Jun 22, 2021	Brand Florian	See Remarks	Buy	2,333	$15.00	$35.0K	0
Jun 22, 2021	Kalali Amir H	Director	Buy	4,666	$15.00	$70.0K	0
Jun 22, 2021	Rao Srinivas	See Remarks	Buy	3,500	$15.00	$52.5K	0

ATAI Insider Buying Activity

The following table shows recent insider purchases of Atai Beckley Inc. (ATAI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 16, 2023	Brand Florian	See Remarks	Buy	20,000	$1.16	$23.1K	0
Sep 13, 2023	Brand Florian	See Remarks	Buy	40,000	$1.45	$58.0K	0
Mar 29, 2023	Brand Florian	See Remarks	Buy	70,000	$1.48	$103.6K	0
Jun 22, 2021	Angermayer Christian	Director	Buy	700,000	$15.00	$10.50M	0
Jun 22, 2021	Brand Florian	See Remarks	Buy	2,333	$15.00	$35.0K	0
Jun 22, 2021	Kalali Amir H	Director	Buy	4,666	$15.00	$70.0K	0
Jun 22, 2021	Rao Srinivas	See Remarks	Buy	3,500	$15.00	$52.5K	0

ATAI Insider Selling Activity

The following table shows recent insider sales of Atai Beckley Inc. (ATAI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 21, 2025	Craig Kevin James	Chief Medical Officer	Sell	11,563	$1.35	$15.6K	0
Mar 21, 2025	Johnson Anne Nagengast	Chief Financial Officer	Sell	33,545	$1.35	$45.3K	0
Mar 21, 2025	Kirpekar Sahil	Chief Business Officer	Sell	48,563	$1.35	$65.6K	0
Mar 21, 2025	Rao Srinivas	See Remarks	Sell	75,418	$1.35	$101.8K	0
Mar 21, 2025	Short Glenn Frank	Chief Scientific Officer	Sell	13,161	$1.35	$17.8K	0
Sep 26, 2024	ATAI Life Sciences N.V.	10% Owner	Sell	2,660,000	$6.05	$16.09M1.4% OS	0
May 16, 2024	Brand Florian	See Remarks	Sell	151,303	$1.92	$290.5K	0
Apr 2, 2024	Johnson Anne Nagengast	Chief Financial Officer	Sell	27,410	$1.85	$50.7K	0
Apr 2, 2024	Kirpekar Sahil	Chief Business Officer	Sell	35,801	$1.85	$66.2K	0
Apr 2, 2024	Rao Srinivas	See Remarks	Sell	61,640	$1.85	$114.0K	0

ATAI Insiders

Johnson Anne Nagengast

Chief Financial Officer

Sold $96.0K

2 tradesLast: Mar 21, 2025

Short Glenn Frank

Chief Scientific Officer

Sold $17.8K

1 tradesLast: Mar 21, 2025

Chief Business Officer

Sold $131.8K

2 tradesLast: Mar 21, 2025

Craig Kevin James

Chief Medical Officer

Sold $15.6K

1 tradesLast: Mar 21, 2025

See Remarks

Bought $52.5KSold $215.8K

3 tradesLast: Mar 21, 2025

ATAI Life Sciences N.V.

10% Owner

Sold $16.09M

1 tradesLast: Sep 26, 2024

See Remarks

Bought $219.6KSold $290.5K

5 tradesLast: May 16, 2024

Angermayer Christian

Director

Bought $10.50M

1 tradesLast: Jun 22, 2021

Director

Bought $70.0K

1 tradesLast: Jun 22, 2021

Similar Stocks to ATAI

VRTX

Vertex Pharmaceuticals Incorporated

$132.26B

REGN

Regeneron Pharmaceuticals, Inc.

$83.21B

MRNA

Moderna, Inc.

$57.75B

RVMD

Revolution Medicines, Inc.

$44.15B

INSM

Insmed Incorporated

$27.37B

INCY

Incyte Corporation

$25.69B

UTHR

United Therapeutics Corporation

$20.70B

NBIX

Neurocrine Biosciences, Inc.

$15.65B

Related Insider Trading Data

Healthcare Sector Insider Trading Biotechnology Insider Trading Insider Buying CEO Purchases Cluster Buys What Is Insider Trading?